Alihossein saberi | Male infertility | Outstanding Scientist Award

Dr. Alihossein saberi | male infertility | Outstanding Scientist Award

professor| Ahwaz Jundishapour University of  Medical Sciences, Iran

Dr. Alihossein Saberi is an accomplished molecular geneticist and Associate Professor at Ahvaz Jundishapur University of Medical Sciences. With a career spanning over three decades, he has held several academic and administrative positions, including Head of the Department of Medical Genetics. He earned his PhD in Molecular Medicine from Kyoto University, Japan, following a master’s in Radiation Biology from Tarbiat Modarres University, Iran. Dr. Saberi has taught and mentored extensively in molecular biology, genetics, and radiation biology. He has authored numerous research articles and textbooks, contributing significantly to the field of molecular genetics, particularly in cancer genomics, male infertility, and genetic disorders. He remains deeply involved in collaborative international research. Dr. Saberi is known for integrating teaching, administration, and impactful research to advance medical genetics education and practice in Iran and beyond.

Profile

🎓 Education

Dr. Saberi earned his PhD in Molecular Medicine from the Graduate School of Medicine at Kyoto University, Japan, between 2004 and 2007. Prior to this, he underwent a research traineeship at the same institution from 2003 to 2004. He completed his Master of Science in Radiation Biology in 1992 at Tarbiat Modarres University, Tehran, Iran, where he gained strong foundational knowledge in biomedical sciences. His education trajectory reflects a continuous focus on molecular and cellular biology, particularly genetic mechanisms underlying human health and disease. His exposure to international research environments has significantly shaped his academic and professional outlook, equipping him with advanced techniques in gene expression, molecular diagnostics, and cancer genomics. These academic qualifications have been central to his role in establishing and leading educational and research initiatives in medical genetics in Iran, enhancing both curriculum development and translational research in the domain of human genetics.

🧪 Experience

Dr. Saberi began his academic career in 1992 as a lecturer at Ahvaz Jundishapur University of Medical Sciences, advancing to Assistant Professor (2007–2013), Associate Professor (since 2013), and Head of the Department of Medical Genetics (since 2014). He also served as Deputy of Educational Affairs (1998–1999) and Dean of the Paramedical Faculty (1999–2003), showcasing his administrative leadership. Over the years, he has taught various core subjects such as Molecular Biology, Medical Genetics, and Radiation Biology. His teaching spans over 30 years and is supported by a strong research portfolio and international collaborations. His leadership has led to the development of molecular genetics curricula and enhanced the university’s role in medical genetics research and diagnostics. His blend of academic, research, and administrative roles reflects a holistic contribution to the medical education and healthcare system in Iran, making him a key figure in advancing genetics education and clinical research in the region.

🏅 Awards and Honors

Dr. Alihossein Saberi’s professional excellence is recognized through his appointment as Head of the Department of Medical Genetics and his pivotal role in curriculum reform and academic leadership at Ahvaz Jundishapur University of Medical Sciences. Although specific awards are not listed, his career progression—from lecturer to associate professor and departmental head—underscores recognition of his academic contributions. His participation in international collaborations and co-authorship of high-impact publications in renowned journals such as Genetics in Medicine, Clinical Genitourinary Cancer, and International Journal of Biological Macromolecules reflects international recognition and scientific credibility. Authoring textbooks in Persian further demonstrates his commitment to knowledge dissemination in the native language. His contributions to both education and research continue to position him as a respected expert in the Iranian academic community and an influential collaborator on global genetic research projects, often cited for his work in oncology, neurogenetics, and reproductive genetics.

🔬 Research Focus

Dr. Saberi’s research focuses on molecular genetics with special emphasis on cancer biology, reproductive genetics, and genetic basis of neurodevelopmental disorders. He explores the regulatory role of microRNAs, gene polymorphisms, and novel genetic markers in disease susceptibility and progression. Recent studies include investigations on microRNA-32 in prostate cancer, FSHB polymorphisms in male infertility, and co-delivery of gene therapies in hepatocellular carcinoma. His participation in multi-institutional genomic projects has led to groundbreaking findings in INPP4A-related neurodevelopmental disorders and biallelic mutations in ZBTB11 and MED27 genes. Using bioinformatics and translational genetics approaches, he aims to bridge the gap between molecular insights and clinical applications. He also explores the genetic basis of recurrent implantation failure and precision medicine in oncology. His collaborative work with international consortia highlights his commitment to global research excellence in human genetics, positioning him as a significant contributor to personalized medicine and molecular diagnostics.

Conclusion

Dr. Alihossein Saberi is a leading molecular geneticist whose work spans academia, research, and administration, with a legacy of advancing genetic medicine education and research in Iran through decades of dedicated service, innovation, and collaboration.

Publications
  • Gold nanoparticles in combination with megavoltage radiation energy increased radiosensitization and apoptosis in colon cancer HT-29 cells

    International Journal of Radiation Biology
    2017 | Journal article

    EID:

    2-s2.0-84994131604

    CONTRIBUTORS: Saberi, A.; Shahbazi-Gahrouei, D.; Abbasian, M.; Fesharaki, M.; Baharlouei, A.; Arab-Bafrani, Z.
  • Impact of prolonged fraction delivery time modelling stereotactic body radiation therapy with high dose hypofractionation on the killing of cultured ACHN renal cell carcinoma cell line

    Journal of Biomedical Physics and Engineering
    2017 | Journal article

    EID:

    2-s2.0-85029830802

    CONTRIBUTORS: Khorramizadeh, M.; Saberi, A.; Tahmasebi-birgani, M.; Shokrani, P.; Amouhedari, A.
  • The first report of a 290-bp deletion in β-globin gene in the south of Iran

    Iranian Biomedical Journal
    2017 | Journal article

    EID:

    2-s2.0-85012202227

    CONTRIBUTORS: Hamid, M.; Nejad, L.D.; Shariati, G.; Galehdari, H.; Saberi, A.; Mohammadi-Anaei, M.

PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri
  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan
  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh
  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan